APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Drug Delivery Technology

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Nasal Drug Delivery Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchNasal Drug Delivery Technology Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Drug Delivery Technology Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Nasal Drug Delivery Technology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Drug Delivery Technology Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Drug Delivery Technology Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Nasal Drug Delivery Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nasal Drug Delivery Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nasal Drug Delivery Technology include Johnson & Johnson, Novartis AG, Merck & Co., Inc., Pfizer, Inc, Shin Nippon Biomedical Laboratories, Promius Pharma, LLC, PendoPharm, Inc, OptiNose, Inc and Glaxosmithkline PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Nasal Drug Delivery Technology market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nasal Drug Delivery Technology and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nasal Drug Delivery Technology revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Nasal Drug Delivery Technology market size, projected growth trends, production technologies, key applications, and end-use industries.

Nasal Drug Delivery Technology Segment by Company

Johnson & Johnson

Novartis AG

Merck & Co., Inc.

Pfizer, Inc

Shin Nippon Biomedical Laboratories

Promius Pharma, LLC

PendoPharm, Inc

OptiNose, Inc

Glaxosmithkline PLC

ENT Technologies Pty. Ltd

Douglas Pharmaceuticals Ltd

Dickinson and Company

Cadila Pharmaceuticals Ltd

BF Ascher & Company, Inc.

Becton, Dickinson and Company

Aptargroup, Inc.

Aegis Therapeutics LLC

3M United States

Nasal Drug Delivery Technology Segment by Type

Pressurized Type

Non-pressurized Type

Nasal Drug Delivery Technology Segment by Application

Asthma

Rhinitis

Nasal Congestion

Other

Nasal Drug Delivery Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Drug Delivery Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Drug Delivery Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Drug Delivery Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Nasal Drug Delivery Technology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nasal Drug Delivery Technology industry.

Chapter 3: Detailed analysis of Nasal Drug Delivery Technology companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nasal Drug Delivery Technologyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nasal Drug Delivery Technology Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Pressurized Type Table 3. Key Players of Non-pressurized Type Table 4. Global Nasal Drug Delivery Technology Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Asthma Table 6. Key Players of Rhinitis Table 7. Key Players of Nasal Congestion Table 8. Key Players of Other Table 9. Global Nasal Drug Delivery Technology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Nasal Drug Delivery Technology Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Nasal Drug Delivery Technology Market Share by Region (2021-2026) Table 12. Global Nasal Drug Delivery Technology Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Nasal Drug Delivery Technology Market Share by Region (2027-2032) Table 14. Nasal Drug Delivery Technology Industry Trends Table 15. Nasal Drug Delivery Technology Industry Drivers Table 16. Nasal Drug Delivery Technology Industry Opportunities and Challenges Table 17. Nasal Drug Delivery Technology Industry Restraints Table 18. Global Nasal Drug Delivery Technology Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Nasal Drug Delivery Technology Revenue Market Share by Company (2021-2026) Table 20. Global Nasal Drug Delivery Technology Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Nasal Drug Delivery Technology Key Company Head Office and Area Served Table 22. Global Nasal Drug Delivery Technology Company, Product Type & Application Table 23. Global Nasal Drug Delivery Technology Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Nasal Drug Delivery Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Nasal Drug Delivery Technology Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nasal Drug Delivery Technology Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Nasal Drug Delivery Technology Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Nasal Drug Delivery Technology Revenue Market Share by Type (2021-2026) Table 30. Global Nasal Drug Delivery Technology Revenue Market Share by Type (2027-2032) Table 31. Global Nasal Drug Delivery Technology Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Nasal Drug Delivery Technology Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Nasal Drug Delivery Technology Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Nasal Drug Delivery Technology Revenue Market Share by Application (2021-2026) Table 35. Global Nasal Drug Delivery Technology Revenue Market Share by Application (2027-2032) Table 36. Johnson & Johnson Company Information Table 37. Johnson & Johnson Business Overview Table 38. Johnson & Johnson Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Johnson & Johnson Nasal Drug Delivery Technology Product Portfolio Table 40. Johnson & Johnson Recent Development Table 41. Novartis AG Company Information Table 42. Novartis AG Business Overview Table 43. Novartis AG Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Novartis AG Nasal Drug Delivery Technology Product Portfolio Table 45. Novartis AG Recent Development Table 46. Merck & Co., Inc. Company Information Table 47. Merck & Co., Inc. Business Overview Table 48. Merck & Co., Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Merck & Co., Inc. Nasal Drug Delivery Technology Product Portfolio Table 50. Merck & Co., Inc. Recent Development Table 51. Pfizer, Inc Company Information Table 52. Pfizer, Inc Business Overview Table 53. Pfizer, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Pfizer, Inc Nasal Drug Delivery Technology Product Portfolio Table 55. Pfizer, Inc Recent Development Table 56. Shin Nippon Biomedical Laboratories Company Information Table 57. Shin Nippon Biomedical Laboratories Business Overview Table 58. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Portfolio Table 60. Shin Nippon Biomedical Laboratories Recent Development Table 61. Promius Pharma, LLC Company Information Table 62. Promius Pharma, LLC Business Overview Table 63. Promius Pharma, LLC Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Promius Pharma, LLC Nasal Drug Delivery Technology Product Portfolio Table 65. Promius Pharma, LLC Recent Development Table 66. PendoPharm, Inc Company Information Table 67. PendoPharm, Inc Business Overview Table 68. PendoPharm, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. PendoPharm, Inc Nasal Drug Delivery Technology Product Portfolio Table 70. PendoPharm, Inc Recent Development Table 71. OptiNose, Inc Company Information Table 72. OptiNose, Inc Business Overview Table 73. OptiNose, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. OptiNose, Inc Nasal Drug Delivery Technology Product Portfolio Table 75. OptiNose, Inc Recent Development Table 76. Glaxosmithkline PLC Company Information Table 77. Glaxosmithkline PLC Business Overview Table 78. Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Glaxosmithkline PLC Nasal Drug Delivery Technology Product Portfolio Table 80. Glaxosmithkline PLC Recent Development Table 81. ENT Technologies Pty. Ltd Company Information Table 82. ENT Technologies Pty. Ltd Business Overview Table 83. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Portfolio Table 85. ENT Technologies Pty. Ltd Recent Development Table 86. Douglas Pharmaceuticals Ltd Company Information Table 87. Douglas Pharmaceuticals Ltd Business Overview Table 88. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio Table 90. Douglas Pharmaceuticals Ltd Recent Development Table 91. Dickinson and Company Company Information Table 92. Dickinson and Company Business Overview Table 93. Dickinson and Company Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Dickinson and Company Nasal Drug Delivery Technology Product Portfolio Table 95. Dickinson and Company Recent Development Table 96. Cadila Pharmaceuticals Ltd Company Information Table 97. Cadila Pharmaceuticals Ltd Business Overview Table 98. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio Table 100. Cadila Pharmaceuticals Ltd Recent Development Table 101. BF Ascher & Company, Inc. Company Information Table 102. BF Ascher & Company, Inc. Business Overview Table 103. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Portfolio Table 105. BF Ascher & Company, Inc. Recent Development Table 106. Becton, Dickinson and Company Company Information Table 107. Becton, Dickinson and Company Business Overview Table 108. Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Becton, Dickinson and Company Nasal Drug Delivery Technology Product Portfolio Table 110. Becton, Dickinson and Company Recent Development Table 111. Aptargroup, Inc. Company Information Table 112. Aptargroup, Inc. Business Overview Table 113. Aptargroup, Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Aptargroup, Inc. Nasal Drug Delivery Technology Product Portfolio Table 115. Aptargroup, Inc. Recent Development Table 116. Aegis Therapeutics LLC Company Information Table 117. Aegis Therapeutics LLC Business Overview Table 118. Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Portfolio Table 120. Aegis Therapeutics LLC Recent Development Table 121. 3M United States Company Information Table 122. 3M United States Business Overview Table 123. 3M United States Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. 3M United States Nasal Drug Delivery Technology Product Portfolio Table 125. 3M United States Recent Development Table 126. North America Nasal Drug Delivery Technology Market Size by Type (2021-2026) & (US$ Million) Table 127. North America Nasal Drug Delivery Technology Market Size by Type (2027-2032) & (US$ Million) Table 128. North America Nasal Drug Delivery Technology Market Size by Application (2021-2026) & (US$ Million) Table 129. North America Nasal Drug Delivery Technology Market Size by Application (2027-2032) & (US$ Million) Table 130. North America Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. North America Nasal Drug Delivery Technology Market Size by Country (2021-2026) Table 132. North America Nasal Drug Delivery Technology Market Size by Country (2027-2032) Table 133. Europe Nasal Drug Delivery Technology Market Size by Type (2021-2026) & (US$ Million) Table 134. Europe Nasal Drug Delivery Technology Market Size by Type (2027-2032) & (US$ Million) Table 135. Europe Nasal Drug Delivery Technology Market Size by Application (2021-2026) & (US$ Million) Table 136. Europe Nasal Drug Delivery Technology Market Size by Application (2027-2032) & (US$ Million) Table 137. Europe Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Nasal Drug Delivery Technology Market Size by Country (2021-2026) Table 139. Europe Nasal Drug Delivery Technology Market Size by Country (2027-2032) Table 140. China Nasal Drug Delivery Technology Market Size by Type (2021-2026) & (US$ Million) Table 141. China Nasal Drug Delivery Technology Market Size by Type (2027-2032) & (US$ Million) Table 142. China Nasal Drug Delivery Technology Market Size by Application (2021-2026) & (US$ Million) Table 143. China Nasal Drug Delivery Technology Market Size by Application (2027-2032) & (US$ Million) Table 144. Asia Nasal Drug Delivery Technology Market Size by Type (2021-2026) & (US$ Million) Table 145. Asia Nasal Drug Delivery Technology Market Size by Type (2027-2032) & (US$ Million) Table 146. Asia Nasal Drug Delivery Technology Market Size by Application (2021-2026) & (US$ Million) Table 147. Asia Nasal Drug Delivery Technology Market Size by Application (2027-2032) & (US$ Million) Table 148. Asia Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Nasal Drug Delivery Technology Market Size by Country (2021-2026) Table 150. Asia Nasal Drug Delivery Technology Market Size by Country (2027-2032) Table 151. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Type (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Type (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Application (2021-2026) & (US$ Million) Table 154. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Application (2027-2032) & (US$ Million) Table 155. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 156. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2021-2026) Table 157. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Nasal Drug Delivery Technology Product Image Figure 2. Global Nasal Drug Delivery Technology Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Nasal Drug Delivery Technology Market Share by Type: 2025 VS 2032 Figure 4. Pressurized Type Image Figure 5. Non-pressurized Type Image Figure 6. Global Nasal Drug Delivery Technology Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Nasal Drug Delivery Technology Market Share by Application: 2025 VS 2032 Figure 8. Asthma Image Figure 9. Rhinitis Image Figure 10. Nasal Congestion Image Figure 11. Other Image Figure 12. Global Nasal Drug Delivery Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 14. Global Nasal Drug Delivery Technology Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Nasal Drug Delivery Technology Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Nasal Drug Delivery Technology Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Nasal Drug Delivery Technology Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Nasal Drug Delivery Technology Revenue Market Share by Type (2021-2032) Figure 21. Global Nasal Drug Delivery Technology Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Nasal Drug Delivery Technology Revenue Market Share by Application (2021-2032) Figure 23. North America Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 24. North America Nasal Drug Delivery Technology Market Share by Type (2021-2032) Figure 25. North America Nasal Drug Delivery Technology Market Share by Application (2021-2032) Figure 26. North America Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 27. United States Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 28. Canada Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 30. Europe Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 31. Europe Nasal Drug Delivery Technology Market Share by Type (2021-2032) Figure 32. Europe Nasal Drug Delivery Technology Market Share by Application (2021-2032) Figure 33. Europe Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 34. Germany Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 35. France Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 37. Italy Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 38. Russia Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 40. China Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 41. China Nasal Drug Delivery Technology Market Share by Type (2021-2032) Figure 42. China Nasal Drug Delivery Technology Market Share by Application (2021-2032) Figure 43. Asia Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 44. Asia Nasal Drug Delivery Technology Market Share by Type (2021-2032) Figure 45. Asia Nasal Drug Delivery Technology Market Share by Application (2021-2032) Figure 46. Asia Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 47. Japan Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 51. India Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 52. Australia Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Nasal Drug Delivery Technology Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Nasal Drug Delivery Technology Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Nasal Drug Delivery Technology Market Share by Country (2021-2032) Figure 57. Brazil Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 62. UAE Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 64. Chile Nasal Drug Delivery Technology Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Pressurized Type
  • Non-pressurized Type
Applications
  • Asthma
  • Rhinitis
  • Nasal Congestion
  • Other
Companies covered
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co., Inc.
  • Pfizer, Inc
  • Shin Nippon Biomedical Laboratories
  • Promius Pharma, LLC
  • PendoPharm, Inc
  • OptiNose, Inc
  • Glaxosmithkline PLC
  • ENT Technologies Pty. Ltd
  • Douglas Pharmaceuticals Ltd
  • Dickinson and Company
  • Cadila Pharmaceuticals Ltd
  • BF Ascher & Company, Inc.
  • Becton, Dickinson and Company
  • Aptargroup, Inc.
  • Aegis Therapeutics LLC
  • 3M United States

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Nasal Drug Delivery Technology Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Pressurized Type
  5. 1.2.3 Non-pressurized Type
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Nasal Drug Delivery Technology Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Asthma
  9. 1.3.3 Rhinitis
  10. 1.3.4 Nasal Congestion
  11. 1.3.5 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Nasal Drug Delivery Technology Growth Trends by Region
  14. 1.5.1 Global Nasal Drug Delivery Technology Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Nasal Drug Delivery Technology Market Size by Region (2021-2026)
  16. 1.5.3 Nasal Drug Delivery Technology Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Nasal Drug Delivery Technology Market Dynamics
  1. 2.1 Nasal Drug Delivery Technology Industry Trends
  2. 2.2 Nasal Drug Delivery Technology Industry Drivers
  3. 2.3 Nasal Drug Delivery Technology Industry Opportunities and Challenges
  4. 2.4 Nasal Drug Delivery Technology Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Nasal Drug Delivery Technology Revenue by Company (2021-2026)
  2. 3.2 Global Nasal Drug Delivery Technology Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Nasal Drug Delivery Technology Key Company Head office and Area Served
  4. 3.4 Global Nasal Drug Delivery Technology Company, Product Type & Application
  5. 3.5 Global Nasal Drug Delivery Technology Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Nasal Drug Delivery Technology Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Nasal Drug Delivery Technology Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Nasal Drug Delivery Technology Tier 1, Tier 2, and Tier 3
4 Nasal Drug Delivery Technology Market by Type
  1. 4.1 Global Nasal Drug Delivery Technology Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Nasal Drug Delivery Technology Market Size by Type (2021-2032)
  3. 4.3 Global Nasal Drug Delivery Technology Market Size Share by Type (2021-2032)
5 Nasal Drug Delivery Technology Market by Application
  1. 5.1 Global Nasal Drug Delivery Technology Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Nasal Drug Delivery Technology Market Size by Application (2021-2032)
  3. 5.3 Global Nasal Drug Delivery Technology Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Johnson & Johnson Nasal Drug Delivery Technology Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis AG Nasal Drug Delivery Technology Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Merck & Co., Inc.
  14. 6.3.1 Merck & Co., Inc. Company Information
  15. 6.3.2 Merck & Co., Inc. Business Overview
  16. 6.3.3 Merck & Co., Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Merck & Co., Inc. Nasal Drug Delivery Technology Product Portfolio
  18. 6.3.5 Merck & Co., Inc. Recent Developments
  19. 6.4 Pfizer, Inc
  20. 6.4.1 Pfizer, Inc Company Information
  21. 6.4.2 Pfizer, Inc Business Overview
  22. 6.4.3 Pfizer, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pfizer, Inc Nasal Drug Delivery Technology Product Portfolio
  24. 6.4.5 Pfizer, Inc Recent Developments
  25. 6.5 Shin Nippon Biomedical Laboratories
  26. 6.5.1 Shin Nippon Biomedical Laboratories Company Information
  27. 6.5.2 Shin Nippon Biomedical Laboratories Business Overview
  28. 6.5.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Product Portfolio
  30. 6.5.5 Shin Nippon Biomedical Laboratories Recent Developments
  31. 6.6 Promius Pharma, LLC
  32. 6.6.1 Promius Pharma, LLC Company Information
  33. 6.6.2 Promius Pharma, LLC Business Overview
  34. 6.6.3 Promius Pharma, LLC Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Promius Pharma, LLC Nasal Drug Delivery Technology Product Portfolio
  36. 6.6.5 Promius Pharma, LLC Recent Developments
  37. 6.7 PendoPharm, Inc
  38. 6.7.1 PendoPharm, Inc Company Information
  39. 6.7.2 PendoPharm, Inc Business Overview
  40. 6.7.3 PendoPharm, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 PendoPharm, Inc Nasal Drug Delivery Technology Product Portfolio
  42. 6.7.5 PendoPharm, Inc Recent Developments
  43. 6.8 OptiNose, Inc
  44. 6.8.1 OptiNose, Inc Company Information
  45. 6.8.2 OptiNose, Inc Business Overview
  46. 6.8.3 OptiNose, Inc Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 OptiNose, Inc Nasal Drug Delivery Technology Product Portfolio
  48. 6.8.5 OptiNose, Inc Recent Developments
  49. 6.9 Glaxosmithkline PLC
  50. 6.9.1 Glaxosmithkline PLC Company Information
  51. 6.9.2 Glaxosmithkline PLC Business Overview
  52. 6.9.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Product Portfolio
  54. 6.9.5 Glaxosmithkline PLC Recent Developments
  55. 6.10 ENT Technologies Pty. Ltd
  56. 6.10.1 ENT Technologies Pty. Ltd Company Information
  57. 6.10.2 ENT Technologies Pty. Ltd Business Overview
  58. 6.10.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Product Portfolio
  60. 6.10.5 ENT Technologies Pty. Ltd Recent Developments
  61. 6.11 Douglas Pharmaceuticals Ltd
  62. 6.11.1 Douglas Pharmaceuticals Ltd Company Information
  63. 6.11.2 Douglas Pharmaceuticals Ltd Business Overview
  64. 6.11.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
  66. 6.11.5 Douglas Pharmaceuticals Ltd Recent Developments
  67. 6.12 Dickinson and Company
  68. 6.12.1 Dickinson and Company Company Information
  69. 6.12.2 Dickinson and Company Business Overview
  70. 6.12.3 Dickinson and Company Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
  72. 6.12.5 Dickinson and Company Recent Developments
  73. 6.13 Cadila Pharmaceuticals Ltd
  74. 6.13.1 Cadila Pharmaceuticals Ltd Company Information
  75. 6.13.2 Cadila Pharmaceuticals Ltd Business Overview
  76. 6.13.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Product Portfolio
  78. 6.13.5 Cadila Pharmaceuticals Ltd Recent Developments
  79. 6.14 BF Ascher & Company, Inc.
  80. 6.14.1 BF Ascher & Company, Inc. Company Information
  81. 6.14.2 BF Ascher & Company, Inc. Business Overview
  82. 6.14.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Product Portfolio
  84. 6.14.5 BF Ascher & Company, Inc. Recent Developments
  85. 6.15 Becton, Dickinson and Company
  86. 6.15.1 Becton, Dickinson and Company Company Information
  87. 6.15.2 Becton, Dickinson and Company Business Overview
  88. 6.15.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Product Portfolio
  90. 6.15.5 Becton, Dickinson and Company Recent Developments
  91. 6.16 Aptargroup, Inc.
  92. 6.16.1 Aptargroup, Inc. Company Information
  93. 6.16.2 Aptargroup, Inc. Business Overview
  94. 6.16.3 Aptargroup, Inc. Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Aptargroup, Inc. Nasal Drug Delivery Technology Product Portfolio
  96. 6.16.5 Aptargroup, Inc. Recent Developments
  97. 6.17 Aegis Therapeutics LLC
  98. 6.17.1 Aegis Therapeutics LLC Company Information
  99. 6.17.2 Aegis Therapeutics LLC Business Overview
  100. 6.17.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Product Portfolio
  102. 6.17.5 Aegis Therapeutics LLC Recent Developments
  103. 6.18 3M United States
  104. 6.18.1 3M United States Company Information
  105. 6.18.2 3M United States Business Overview
  106. 6.18.3 3M United States Nasal Drug Delivery Technology Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 3M United States Nasal Drug Delivery Technology Product Portfolio
  108. 6.18.5 3M United States Recent Developments
7 North America
  1. 7.1 North America Nasal Drug Delivery Technology Market Size (2021-2032)
  2. 7.2 North America Nasal Drug Delivery Technology Market Size by Type
  3. 7.2.1 North America Nasal Drug Delivery Technology Market Size by Type (2021-2026)
  4. 7.2.2 North America Nasal Drug Delivery Technology Market Size by Type (2027-2032)
  5. 7.2.3 North America Nasal Drug Delivery Technology Market Share by Type (2021-2032)
  6. 7.3 North America Nasal Drug Delivery Technology Market Size by Application
  7. 7.3.1 North America Nasal Drug Delivery Technology Market Size by Application (2021-2026)
  8. 7.3.2 North America Nasal Drug Delivery Technology Market Size by Application (2027-2032)
  9. 7.3.3 North America Nasal Drug Delivery Technology Market Share by Application (2021-2032)
  10. 7.4 North America Nasal Drug Delivery Technology Market Size by Country
  11. 7.4.1 North America Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  13. 7.4.3 North America Nasal Drug Delivery Technology Market Size by Country (2027-2032)
  14. 7.4.4 North America Nasal Drug Delivery Technology Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Nasal Drug Delivery Technology Market Size (2021-2032)
  2. 8.2 Europe Nasal Drug Delivery Technology Market Size by Type
  3. 8.2.1 Europe Nasal Drug Delivery Technology Market Size by Type (2021-2026)
  4. 8.2.2 Europe Nasal Drug Delivery Technology Market Size by Type (2027-2032)
  5. 8.2.3 Europe Nasal Drug Delivery Technology Market Share by Type (2021-2032)
  6. 8.3 Europe Nasal Drug Delivery Technology Market Size by Application
  7. 8.3.1 Europe Nasal Drug Delivery Technology Market Size by Application (2021-2026)
  8. 8.3.2 Europe Nasal Drug Delivery Technology Market Size by Application (2027-2032)
  9. 8.3.3 Europe Nasal Drug Delivery Technology Market Share by Application (2021-2032)
  10. 8.4 Europe Nasal Drug Delivery Technology Market Size by Country
  11. 8.4.1 Europe Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  13. 8.4.3 Europe Nasal Drug Delivery Technology Market Size by Country (2027-2032)
  14. 8.4.4 Europe Nasal Drug Delivery Technology Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Nasal Drug Delivery Technology Market Size (2021-2032)
  2. 9.2 China Nasal Drug Delivery Technology Market Size by Type
  3. 9.2.1 China Nasal Drug Delivery Technology Market Size by Type (2021-2026)
  4. 9.2.2 China Nasal Drug Delivery Technology Market Size by Type (2027-2032)
  5. 9.2.3 China Nasal Drug Delivery Technology Market Share by Type (2021-2032)
  6. 9.3 China Nasal Drug Delivery Technology Market Size by Application
  7. 9.3.1 China Nasal Drug Delivery Technology Market Size by Application (2021-2026)
  8. 9.3.2 China Nasal Drug Delivery Technology Market Size by Application (2027-2032)
  9. 9.3.3 China Nasal Drug Delivery Technology Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Nasal Drug Delivery Technology Market Size (2021-2032)
  2. 10.2 Asia Nasal Drug Delivery Technology Market Size by Type
  3. 10.2.1 Asia Nasal Drug Delivery Technology Market Size by Type (2021-2026)
  4. 10.2.2 Asia Nasal Drug Delivery Technology Market Size by Type (2027-2032)
  5. 10.2.3 Asia Nasal Drug Delivery Technology Market Share by Type (2021-2032)
  6. 10.3 Asia Nasal Drug Delivery Technology Market Size by Application
  7. 10.3.1 Asia Nasal Drug Delivery Technology Market Size by Application (2021-2026)
  8. 10.3.2 Asia Nasal Drug Delivery Technology Market Size by Application (2027-2032)
  9. 10.3.3 Asia Nasal Drug Delivery Technology Market Share by Application (2021-2032)
  10. 10.4 Asia Nasal Drug Delivery Technology Market Size by Country
  11. 10.4.1 Asia Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  13. 10.4.3 Asia Nasal Drug Delivery Technology Market Size by Country (2027-2032)
  14. 10.4.4 Asia Nasal Drug Delivery Technology Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Nasal Drug Delivery Technology Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Nasal Drug Delivery Technology Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Nasal Drug Delivery Technology Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Nasal Drug Delivery Technology Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst